“Clinical trials referral resource. Targeted therapy in squamous cell cancers of the head and neck.”, Oncology (Williston Park), vol. 16, no. 5, pp. 621-2, 625-6, 2002.
, “Clinical trials referral resource. Current phase III, NCI-supported, Cooperative Group Clinical Trials in breast cancer.”, Oncology (Williston Park), vol. 18, no. 4, pp. 463-4, 467-8, 470, 2004.
, “Pediatric transplantation of the kidney, liver and heart: summary report.”, Pediatr Transplant, vol. 8, no. 1, pp. 75-86, 2004.
, “Clinical trials referral resource. Current phase III breast cancer clinical trials.”, Oncology (Williston Park), vol. 20, no. 7, p. 696, 700, 702, 2006.
, “Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system.”, J Clin Oncol, vol. 25, no. 15, pp. 2127-32, 2007.
, “Recommendations for collection and handling of specimens from group breast cancer clinical trials.”, J Clin Oncol, vol. 26, no. 34, pp. 5638-44, 2008.
, “Early-phase clinical trials in the community: results from the national cancer institute community cancer centers program early-phase working group baseline assessment.”, J Oncol Pract, vol. 9, no. 2, pp. e55-61, 2013.
, “An international Ki67 reproducibility study.”, J Natl Cancer Inst, vol. 105, no. 24, pp. 1897-906, 2013.
, “The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations.”, J Oncol Pract, vol. 9, no. 6, pp. 267-76, 2013.
, “Racial/ethnic differences in clinical trial enrollment, refusal rates, ineligibility, and reasons for decline among patients at sites in the National Cancer Institute's Community Cancer Centers Program.”, Cancer, vol. 120, no. 6, pp. 877-84, 2014.
, “Use of the National Cancer Institute Community Cancer Centers Program screening and accrual log to address cancer clinical trial accrual.”, J Oncol Pract, vol. 10, no. 2, pp. e73-80, 2014.
,